News Stocks Global Health Limited Grants 4,000 ESOPs Under Employee Long Term Share Based Incentive Plan 2024Global Health Limited Grants 4,000 ESOPs Under Employee Long Term Share Based Incentive Plan 2024
Global Health Limited's Nomination and Remuneration Committee approved the grant of 4,000 Employee Stock Options to one employee under the GHL LTIP 2024 Plan on February 03, 2026. The options carry an exercise price of Rs. 2 each and will vest over a maximum period of 5 years, with a 3-year exercise window from the last vesting date. The plan, compliant with SEBI regulations, aims to reward employee performance and enable long-term wealth creation through equity participation.
*this image is generated using AI for illustrative purposes only.
Global health Limited has announced the grant of 4,000 Employee Stock Options (ESOPs) to one employee under its GHL-Employee Long Term Share Based Incentive Plan 2024. The company's Nomination and Remuneration Committee approved this grant during its meeting held on February 03, 2026, in compliance with SEBI regulations.
ESOP Grant Details
The committee meeting, which commenced at 02:30 PM and concluded at 03:00 PM, approved the grant under Part-A of the GHL LTIP 2024 Plan, specifically the GHL Employees Stock Option Scheme, 2024. The grant represents the company's continued commitment to rewarding employee performance and fostering long-term association with key talent.
| Parameter: | Details |
|---|---|
| Total Options Granted: | 4,000 ESOPs |
| Number of Employees: | 1 |
| Exercise Price: | Rs. 2 per option |
| Share Value: | Rs. 2 per equity share |
| Plan Type: | GHL LTIP 2024 Plan (Part-A) |
Plan Structure and Compliance
The GHL LTIP 2024 Plan is designed to reward employees for their association, dedication, and contribution to the company's goals. Global Health Limited views this scheme as a long-term incentive tool that enables employees to become co-owners and create wealth through such ownership. The plan is fully compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Each granted option will result in the allotment of one equity share of Rs. 2 each upon exercise. The purpose of the scheme extends beyond mere compensation, aiming to attract, retain, and motivate key talents by rewarding their performance and encouraging contribution to overall corporate growth and profitability.
Vesting and Exercise Terms
The options granted under the current tranche will vest according to the vesting schedule and conditions outlined in the grant letter, subject to a maximum period of 5 years from the date of grant. Once vested, the options must be exercised within a maximum period of 3 years from the date of vesting of the last instalment of options under the GHL LTIP 2024 Plan.
| Timeline: | Duration |
|---|---|
| Maximum Vesting Period: | 5 years from grant date |
| Exercise Window: | 3 years from last vesting date |
| Current Status: | Options granted, vesting pending |
Regulatory Disclosure
The company has made the necessary disclosures as mandated under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Rahul Ranjan signed the disclosure document, ensuring full regulatory compliance. At this stage, no options have been vested or exercised, and no money has been realized from option exercises.
The grant reflects Global Health Limited's strategic approach to employee retention and motivation, utilizing equity participation as a tool for long-term value creation for both employees and the organization.
Historical Stock Returns for Global Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.37% | +8.08% | -8.54% | -16.77% | +6.78% | +168.05% |
15
